自動調合システム市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00010169
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 165
Buy Now

自動調合システム市場は、2019 年に 4 億 388 万米ドルと評価され、2027 年までに 6 億 8,417 万米ドルに達すると予測されています。 2020 年から 2027 年にかけて 7.0% の CAGR で成長すると予想されています。

自動調合システムは、1 つ以上の薬液を最終容器に組み合わせる装置です。患者の管理用。自動調合システムは、医師と薬剤師の間の不十分な管理コミュニケーション、薬局での重要な保管慣行、類似のラベルを使用する際の混乱など、さまざまな要因によって発生する投薬ミスを回避するのに役立ちます。しかし、自動調合システムにより、調合された製品の調合の精度と効率が向上し、医療従事者の有毒物質への曝露が減少しました。世界の自動調合システム市場は、化学療法や個別化投薬の採用の増加、投薬ミスを最小限に抑える必要性の高まりなどの要因によって牽引されています。ただし、自動調合システムのコストが高いため、市場の成長が妨げられます。さらに、薬剤師の意識の高まりは、世界の自動調合システム市場の成長に大きな機会を提供する可能性があります。

有利な地域自動調合システム市場


市場洞察

化学療法と個別化医療の導入の拡大< /p>

がんは、毎年かなりの数の死亡者を引き起こす悲惨な病気です。疾患は不均一であるため、化学療法や放射線などの標準的な治療法は、患者集団間の治療法として効率的な解決策です。化学療法は、体内で急速に増殖する腫瘍細胞を除去するために強力な化学物質を必要とする薬物療法です。がん細胞は体内の他の細胞に比べて急速に成長し増加するため、化学療法は悪性腫瘍の治療に最もよく使用されます。

次のような新しい治療法が急速に導入されています。腫瘍学における化学療法は、乳がん、肺がん、および前立腺がんに対してより良い治療選択肢を提供すると報告されています。同様に、精密個別医療 (PPM) の分野は、現在および過去の身体的健康および環境経験を捕捉したデータに基づいて、単一の患者または特定のグループに対する治療法を作成するために開発されています。最近、PPM の観点をがんの研究と治療に取り入れることで、主にがんの複雑さと患者間の予測不可能性により、がんとの闘いが大幅に強化されることがいくつかの報告で示されています。

いくつかのメーカーは、化学療法や個別化医薬品向けの自動調合システムを提供しています。たとえば、Pharmoduct (Comecer) は、化学療法や生物学的製剤を含む個別化腫瘍薬の滅菌調製に使用される自動デバイスです。

製品に関するインサイト

< p>重量測定自動配合システムは、世界の自動配合システム市場で最大のシェアを占めています。この部門の成長は、潜在的なエラーの減少とともに、抗腫瘍剤などの IV 剤の調製にこの方法の採用が増加したことに起因しています。また、この市場の有名な企業は、自動配合システムに重量測定技術を使用しています。たとえば、RIVA などの完全自動調合システムは、正確な自動測定方法と重量チェックを使用して、各用量の精度を保証します。

世界の自動調合システム市場、製品タイプ別– 2019& 2027 年


エンド ユーザー インサイト

エンド ユーザーに基づいた自動調合システム市場は、病院、化学療法センターなどに分類されます。病院セグメントは、2019年の世界の自動調剤システム市場で最大のシェアを占めました。このセグメントの成長は、世界的なトレンドへの影響、投薬ミスの増加、最高水準の患者ケアを提供する必要性によるものと考えられます。たとえば、いくつかの研究では、病院薬局における標準誤り率は最大 10% であることが観察されています。その結果、病院にとっては、配合薬剤の安全性の確保と点滴療法の品質とコストの管理が最優先事項となっています。そのため、自動調合システムは安全で効率的な薬局運営に不可欠な要素であると考えられています。さらに、大手企業による戦略的取り組みにより、今後数年間で部門別の成長が拡大する可能性があります。たとえば、オムニセルは、アレゲニー ヘルス ネットワーク (AHN) の一部であるペンシルバニア州ピッツバーグのアレゲニー総合病院が、中央薬局 IV 調剤サービスの調達においてオムニセルと協力したと発表しました。

病院は最高水準の患者ケアを提供する必要性を認識しているため、自動調合システムの需要は予測期間中に安定したペースで増加する可能性があります。

< p>戦略的洞察

需要と供給のギャップを埋めるための市場の運営会社によるコラボレーションと技術パートナーシップは、予測期間中の自動調合システム業界の成長に重要な役割を果たすと予想されます。さらに、投薬ミスを最小限に抑えるニーズの高まりにより、市場の成長が加速すると予測されています。

製品タイプ別

  • 重量測定自動調合システム

    li>

  • 容積自動調合システム

エンドユーザーによる

  • 病院
  • 化学療法センター
  • その他

地理別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • ヨーロッパ
    • フランス
    • ドイツ
    • li>
    • イタリア
    • 英国
    • ロシア
    • その他のヨーロッパ
  • アジア太平洋 ( APAC)
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア
    • 残りアジア太平洋地域
  • 中東およびアジア太平洋地域アフリカ (MEA)
    • 南アフリカ
    • サウジアラビア
    • UAE
    • 中東およびアフリカのその他の地域
  • 南アメリカ
    • ブラジル
    • アルゼンチン
    • 南アメリカのその他の地域

会社概要

  • Baxter International Inc.
  • Braun Melsungen AG
  • Comecer
  • >
  • ICU MEDICAL INC.
  • SA 州グリフォルス
  • OMNICELL INC.
  • EQUASHIELD
  • ARxIUM
  • Weibond テクノロジー
  • 新しいアイコン
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the automated compounding systems?

An automated compounding system is a device that combines one or more drug solutions to a final container for patient administration. Automated Compounding System helps avoid medication error that occurs due to a variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion that was arising out of the use of similar labels.

What are the driving factors for the automated compounding systems market across the globe?

The global automated compounding systems market is being driven by factors such as the growing adoption of chemotherapy and personalized medication, rising need to minimize medication errors. Furthermore, increasing awareness in pharmacists is likely to offer significant opportunities for the growth of the global automated compounding systems.

What are the restraining factors for the automated compounding systems market across the globe?

The high cost of the automated compounding systems is the significant factor that will impede the automated compounding systems market growth. Automated compounding systems have been introduced to the healthcare sector more than a decade ago, but only a few pharmacies use them. The high cost of the devices is one of the significant factors for the hindrance of market growth. Also, disadvantages of automated preparation are the danger of failure/downtime, dependence on the power supply, software (updates), high venture and high maintenance costs, dedicated personnel with extra training, declined worker satisfaction, complication when products are exchanged or added.

The List of Companies - Automated Compounding Systems Market

  1. Baxter International Inc.
  2. Braun Melsungen AG
  3. Comecer
  4. ICU MEDICAL INC
  5. Grifols, S.A.
  6. OMNICELL INC.
  7. EQUASHIELD
  8. ARxIUM
  9. Weibond Technology
  10. NewIcon

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports